publication date: May. 11, 2018
PSA test gets a better grade from USPSTF—it’s a “C” Uncertainty lingers about high-risk groups
By Paul Goldberg
Relying largely on maturing data from the European trials of screening for prostate cancer, the U.S. Preventive Services Task Force has given a better grade—a “C”—to screening for prostate cancer.
An earlier version of the screening guideline, published in 2012, gave PSA a “D,” as in “don’t.”
The updated guideline, published May 8, gives a “C” to screening men between ages 55 and 69. Screening men who are 70 or older gets a “D.”
By relying on new data to acknowledge that PSA screening makes sense for some men, provided that they have gone through shared decision-making with their doctors, USPSTF guidelines are now largely consistent with the guidelines of other major organizations.
“I think that the thirteen-year follow up from the European trial compared to the 10 year, which is what we had in 2012, was critical to moving to the ‘C’ recommendation,” said Alex Krist, a USPSTF member, professor of family medicine and population health at Virginia Commonwealth University, a clinician at the Fairfax Family Practice, and co-director of the Virginia Ambulatory Care Outcomes Research Network. “With the extended extra three years of follow-up, we found that more lives were saved by screening.
“It was only a small increase, it went from 1.07 per thousand screened to … Continue reading PSA test gets a better grade from USPSTF—it’s a “C” Uncertainty lingers about high-risk groups
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.